These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


505 related items for PubMed ID: 19130464

  • 1. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
    Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF, Tseng JF.
    Cancer; 2009 Feb 15; 115(4):741-51. PubMed ID: 19130464
    [Abstract] [Full Text] [Related]

  • 2. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.
    Bilimoria KY, Talamonti MS, Tomlinson JS, Stewart AK, Winchester DP, Ko CY, Bentrem DJ.
    Ann Surg; 2008 Mar 15; 247(3):490-500. PubMed ID: 18376195
    [Abstract] [Full Text] [Related]

  • 3. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
    Bilimoria KY, Bentrem DJ, Merkow RP, Tomlinson JS, Stewart AK, Ko CY, Talamonti MS.
    J Am Coll Surg; 2007 Oct 15; 205(4):558-63. PubMed ID: 17903729
    [Abstract] [Full Text] [Related]

  • 4. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
    Matthews BD, Heniford BT, Reardon PR, Brunicardi FC, Greene FL.
    Am Surg; 2000 Dec 15; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
    Teh SH, Deveney C, Sheppard BC.
    Am J Surg; 2007 May 15; 193(5):610-3; discussion 613. PubMed ID: 17434366
    [Abstract] [Full Text] [Related]

  • 7. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
    Bahra M, Jacob D, Pascher A, Plockinger U, Kristiansen G, Neuhaus P, Langrehr JM.
    J Gastroenterol Hepatol; 2007 Jun 15; 22(6):930-5. PubMed ID: 17489964
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer.
    Hellan M, Sun CL, Artinyan A, Mojica-Manosa P, Bhatia S, Ellenhorn JD, Kim J.
    Pancreas; 2008 Jul 15; 37(1):19-24. PubMed ID: 18580439
    [Abstract] [Full Text] [Related]

  • 11. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
    Shaib Y, Davila J, Naumann C, El-Serag H.
    Am J Gastroenterol; 2007 Jul 15; 102(7):1377-82. PubMed ID: 17403071
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Surgery in malignant pancreatic neuroendocrine tumors.
    Nguyen SQ, Angel LP, Divino CM, Schluender S, Warner RR.
    J Surg Oncol; 2007 Oct 01; 96(5):397-403. PubMed ID: 17469119
    [Abstract] [Full Text] [Related]

  • 15. Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution.
    Dahdaleh FS, Calva-Cerqueira D, Carr JC, Liao J, Mezhir JJ, O'Dorisio TM, Howe JR.
    Ann Surg Oncol; 2012 Mar 01; 19(3):966-72. PubMed ID: 21845496
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.
    Tsuchikawa T, Hirano S, Tanaka E, Kato K, Matsumoto J, Sichinohe T.
    Hepatogastroenterology; 2012 Mar 01; 59(120):2623-6. PubMed ID: 22497945
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.